{"paper_id":"98ddda45-a53b-4257-87bb-7b54d7e75385","body_text":"Endometriosis: A Narrative Review\nAbstract\nAlthough much progress has been made since endometriosis was first scientifically described centuries ago, numerous unanswered questions still surround this chronic, inflammatory condition. For instance, one theory on the pathogenesis of endometriosis suggests that the condition begins from retrograde menstrual flow implanting on surfaces in the abdomen and pelvis (Samson’s theory), which is a logical mechanism given the high rates of endometriosis in patients with obstructive anomalies of the lower genital tract and significant retrograde flow. This explanation has many shortcomings however, as retrograde menstruation occurs more commonly than the reported 10% prevalence of endometriosis. Additionally, endometriosis lesions can be found in areas quite remote from the pelvis, such as the thoracic cavity. As such, research has been increasingly focused on identifying immune, genetic, and local environmental factors that likely play critical roles in the development of endometriosis. This growth of benign endometrial-like tissue outside of the uterus can sometimes be asymptomatic, but it can also cause debilitating pain, infertility, ovarian cysts (endometriomas), and can invade surrounding organs such as the bowel or bladder. There are three main phenotypes of endometriosis: superficial lesions, deeply infiltrating endometriosis (including nodules), and ovarian endometriomas.\nWhile the exact etiology may be obscure, the societal and economic impacts of this condition are undeniable. Patients diagnosed with endometriosis are at a significantly higher risk of absenteeism from work or school, lower quality of life, chronic pelvic pain, and are more likely to receive a mental health diagnosis such as depression or anxiety. Apart from direct and indirect incurred costs to patients (estimated at approximately $5000 per patient annually), at a national level the economic burden of endometriosis exceeds $2 billion annually in Canada, and approaches $80 billion in the USA.\nReferences\nAcién P, Velasco I. Endometriosis: a disease that remains enigmatic. ISRN Obstet Gynecol. 2013;2013:242149. doi:10.1155/2013/242149\nThiel PS, Bougie O, Pudwell J, Shellenberger J, Velez MP, Murji A. Endometriosis and mental health: a population-based cohort study. Am J Obstet Gynecol. 2024. doi:10.1016/j.ajog.2024.01.023\nSoliman AM, Rahal Y, Robert C, Defoy I, Nisbet P, Leyland N, et al. Impact of endometriosis on fatigue and productivity impairment in a cross-sectional survey of Canadian women. J Obstet Gynaecol Can. 2021;43(1):10-18. doi:10.1016/j.jogc.2020.06.022\nSoliman AM, Yang H, Du EX, Kelley C, Winkel C. The direct and indirect costs associated with endometriosis: a systematic literature review. Hum Reprod. 2016;31(4):712-722. doi:10.1093/humrep/dev335\nLevy AR, Osenenko KM, Lozano-Ortega G, Sambrook R, Jeddi M, Bélisle S, et al. Economic burden of surgically confirmed endometriosis in Canada. J Obstet Gynaecol Can. 2011;33(8):830-837. doi:10.1016/s1701-2163(16)34986-6\nAgarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354.e351-354.e312. doi:10.1016/j.ajog.2018.12.039\nBecker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi:10.1093/hropen/hoac009\nLeyland N, Casper R, Laberge P, Singh SS, Allen L, Arendas K, et al. Endometriosis: diagnosis and management. Journal of Endometriosis. 2010;2(3):107-134. doi:10.1177/228402651000200303\nGuerriero S, Ajossa S, Orozco R, Perniciano M, Jurado M, Melis GB, et al. Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in the rectosigmoid: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2016;47(3):281-289. doi:10.1002/uog.15662\nChen-Dixon K, Uzuner C, Mak J, Condous G. Effectiveness of ultrasound for endometriosis diagnosis. Curr Opin Obstet Gynecol. 2022;34(5):324-331. doi:10.1097/gco.0000000000000812\nGoncalves MO, Siufi Neto J, Andres MP, Siufi D, de Mattos LA, Abrao MS. Systematic evaluation of endometriosis by transvaginal ultrasound can accurately replace diagnostic laparoscopy, mainly for deep and ovarian endometriosis. Hum Reprod. 2021;36(6):1492-1500. doi:10.1093/humrep/deab085\nBendifallah S, Dabi Y, Suisse S, Delbos L, Spiers A, Poilblanc M, et al. Validation of a salivary miRNA signature of endometriosis - interim data. NEJMEvid. 2023;2(7):EVIDoa2200282. doi:10.1056/EVIDoa2200282\nBendifallah S, Suisse S, Puchar A, Delbos L, Poilblanc M, Descamps P, et al. Salivary MicroRNA signature for diagnosis of endometriosis. J Clin Med. 2022;11(3).doi:10.3390/jcm11030612\nAbril-Coello R, Correyero-León M, Ceballos-Laita L, Jiménez-Barrio S. Benefits of physical therapy in improving quality of life and pain associated with endometriosis: a systematic review and metaanalysis. Int J Gynaecol Obstet. 2023;162(1):233-243.doi:10.1002/ijgo.14645\nMitchell JB, Chetty S, Kathrada F. Progestins in the symptomatic management of endometriosis: a metaanalysis on their effectiveness and safety. BMC Womens Health. 2022;22(1):526. doi:10.1186/s12905-022-02122-0\nBrown J, Kives S, Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev.2012;2012(3):Cd002122. doi:10.1002/14651858.CD002122.pub2\nRegidor PA, Schindler AE. Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone. Oncotarget. 2017;8(47):83334-83342.doi:10.18632/oncotarget.19833\nMcCormack PL. Dienogest: a review of its use in the treatment of endometriosis. Drugs. 2010;70(16):2073- 2088. doi:10.2165/11206320-000000000-00000\nBedaiwy MA, Mousa NA, Casper RF. Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists. Fertil Steril. 2009;91(4 Suppl):1574-1577. doi:10.1016/j.fertnstert.2008.09.077\nEberle A, Nguyen DB, Smith JP, Mansour FW, Krishnamurthy S, Zakhari A. Medical management of ovarian endometriomas: a systematic review and meta-analysis. Obstet Gynecol. 2024;143(1):53-66.doi:10.1097/aog.0000000000005444\nThiel P, Donders F, Kobylianskii A, Maheux-Lacroix S, Matelski J, Walsh C, et al. The effect of medical management on ovarian endometriomas: a systematic review and meta-analysis. Journal of Minimally Invasive Gynecology. 2023;30(11, Supplement):S9-S10. doi:https://doi.org/10.1016/j.jmig.2023.08.029\nZakhari A, Delpero E, McKeown S, Tomlinson G, Bougie O, Murji A. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(1):96-107. doi:10.1093/humupd/dmaa033\nFalcone T, Wilson JR. Surgical treatment of endometriosis: excision versus ablation of peritoneal disease. J Minim Invasive Gynecol. 2019;26(1):1-2. doi:10.1016/j.jmig.2018.10.008\nBurks C, Lee M, DeSarno M, Findley J, Flyckt R. Excision versus ablation for management of minimal to mild endometriosis: a systematic review and metaanalysis. J Minim Invasive Gynecol. 2021;28(3):587- 597. doi:10.1016/j.jmig.2020.11.028\nHealey M, Cheng C, Kaur H. To excise or ablate endometriosis? A prospective randomized doubleblinded trial after 5-year follow-up. J Minim Invasive Gynecol. 2014;21(6):999-1004. doi:10.1016/j.jmig.2014.04.002\nPundir J, Omanwa K, Kovoor E, Pundir V, Lancaster G, Barton-Smith P. Laparoscopic excision versus ablation for endometriosis-associated pain: an updated systematic review and meta-analysis. J Minim Invasive Gynecol. 2017;24(5):747-756. doi:10.1016/j.jmig.2017.04.008\nBanerjee SK, Ballard KD, Wright JT. Endometriomas as a marker of disease severity. J Minim Invasive Gynecol. 2008;15(5):538-540. doi:10.1016/j.jmig.2008.05.004\nBougie O, McClintock C, Pudwell J, Brogly SB, Velez MP. Long-term follow-up of endometriosis surgery in Ontario: a population-based cohort study. Am J Obstet Gynecol. 2021;225(3):270.e271-270.e219. doi:10.1016/j.ajog.2021.04.237\nSandström A, Bixo M, Johansson M, Bäckström T, Turkmen S. Effect of hysterectomy on pain in women with endometriosis: a population-based registry study. Bjog. 2020;127(13):1628-1635. doi:10.1111/1471-0528.16328\nRizk B, Fischer AS, Lotfy HA, Turki R, Zahed HA, Malik R, et al. Recurrence of endometriosis after hysterectomy. Facts Views Vis Obgyn. 2014;6(4):219-227.\nGrigoriadis G, Daniilidis A, Merlot B, Stratakis K, Dennis T, Crestani A, et al. Surgical treatment of deep endometriosis: impact on spontaneous conception. Best Pract Res Clin Obstet Gynaecol. 2024;93:102455. doi:10.1016/j.bpobgyn.2024.102455\nBrown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014;2014(3):Cd009590. doi:10.1002/14651858. CD009590.pub2\nCasals G, Carrera M, Domínguez JA, Abrão MS, Carmona F. Impact of surgery for deep infiltrative endometriosis before in vitro fertilization: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021;28(7):1303-1312.e1305. doi:10.1016/j.jmig.2021.02.007\nMelo P, Georgiou EX, Johnson N, van Voorst SF, Strandell A, Mol BWJ, et al. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev. 2020;10(10):Cd002125. doi:10.1002/14651858. CD002125.pub4","source_license":"CC0","license_restricted":false}